GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Acorda Therapeutics, Inc. (ACOR) [hlAlert]

Acorda Therapeutics is commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury
and other disorders of the central nervous system. Acorda currently markets Zanaflex Capsules for the management of spasticity. The Company's lead product candidate, Fampridine-SR, for the improvement of walking ability in persons with multiple sclerosis. It develops therapies that restore neurological function to people with spinal cord injury, multiple sclerosis and related conditions of the nervous system.
( Total: 22 Current Stock Recommendations )
Acorda Therapeutics, Inc.   (22)
Sell Hold 18% Buy 73%
Related companies
China Biologic ...   (4)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Flamel Technologies ...   (8)
Buy 100%
Aeterna Zentaris, ...   (12)
Buy 100%
Lannett Co Inc   (4)
Buy 100%
Anika Therapeutics ...   (4)
Buy 100%
Emergent ...   (6)
Buy 100%
Insys Therapeutics ...   (4)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
1/29/2008  
Buy
  
1/31/2008  
Sell
  
6/23/2008  
Hold
  
11/25/2008  
Buy
  
2/24/2009  
Buy
  
3/12/2009  
Buy
  
3/24/2009  
Buy
  
8/5/2009  
Buy
  
10/12/2009  
Sell
  
10/15/2009  
Buy
  
1/25/2010  
Buy
  
12/14/2010  
Hold
  
4/20/2011  
Buy
  
3/15/2012  
Buy
  
7/23/2012  
Buy
  
8/1/2013  
Buy
  
10/1/2013  
Buy
  
11/1/2013  
Buy
  
1/6/2014  
Hold
  
8/19/2014  
Buy
  
10/30/2014  
Hold
  
2/12/2015  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy